Novavax to Host Conference Call and Webcast to Discuss Second Quarter 2017 Financial Results on August 8, 2017
Get Alerts NVAX Hot Sheet
Join SI Premium – FREE
GAITHERSBURG, Md., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its second quarter financial and operating results following the close of U.S. financial markets on Tuesday, August 8, 2017.
Conference call details are as follows:
Date: | Tuesday, August 8, 2017 |
Time: | 4:30 p.m. U.S. Eastern Time (ET) |
Dial-in number: | (877) 212-6076 (Domestic) or (707) 287-9331 (International) |
Passcode: | 15614203 |
Webcast: | www.novavax.com, “Investors”/ “Events” |
Conference call and webcast replay:
Dates: | Starts at 7:30 p.m. ET, August 8, 2017 until 7:30 pm ET, August 15, 2017 | |
Dial-in number: | (855) 859-2056 (Domestic) or (404) 537-3406 (International) | |
Passcode: | 15614203 | |
Webcast: | www.novavax.com, “Investors”/ “Events”, until November 8, 2017 |
About Novavax
Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.
Contact: Investor Relations Novavax, Inc. Andrea N. Flynn, Ph.D. Director, Investor Relations [email protected] 240-268-2000 Westwicke Partners John Woolford [email protected] 443-213-0506 Media Russo Partners, LLC David Schull Todd Davenport, Ph.D. [email protected] 212-845-4271Source: Novavax, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
- Dime Community Bancshares (DCOM) Tops Q1 EPS by 1c
- Sherwin-Williams (SHW) Misses Q1 EPS by 5c, provides guidance
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Davenport, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!